Pandemic Preparedness
Medical Countermeasure & Supply-Chain Disruption
A critical countermeasure input concentrated in one region fails during a demand surge.
Duration
120 min
Injects
6
Audience
National resilience & procurement leads, health logistics, industry liaison, finance
Situation
A respiratory pathogen is driving a national surge in demand for a critical countermeasure — a therapeutic, a diagnostic reagent, or PPE. A single overseas region supplies the majority of one essential input. A combination of export restrictions, a manufacturing halt and freight disruption cuts supply to a fraction of projected need within two weeks — just as demand peaks. Rationing is now unavoidable; the question is how, and how transparently.
Exercise objectives
- Expose single points of failure in the medical supply chain before a real surge does.
- Exercise allocation of a scarce countermeasure across regions and patient groups under an agreed ethical framework.
- Test the levers of manufacturing sovereignty: onshoring, stockpile release, substitution and diplomatic channels.
- Rehearse transparent communication about shortage and rationing without triggering panic-buying.
Capability stress
How hard this scenario tests each of the 10 benchmark dimensions (1–5).
Foresight lens
Getting ready for a threat that HAS a reference class — one that resembles something we have seen (COVID, influenza, known AMR). Plans, playbooks and drills work because the past is a guide.
TUNA profile
Assumptions this scenario windtunnelsfull register →
A4Medical supply chains will keep functioning during a global surge.
Sensitivity: medium · TUNA: U · T
A5Readiness is a controllable quantity you can hit as a target.
Sensitivity: high · TUNA: —
Scenario parameters
Illustrative planning figures for discussion — not operational data.
Trigger
Demand surge + concentrated-supplier disruption
Supply vs. demand
~20% of projected daily need available
Lead time to alternative supply
8–16 weeks
Stockpile cover
Weeks, not months
Substitution options
Partial, clinically inferior
Supplier concentration
Majority of one input from a single region
Roles at the table
National Resilience Coordinator
Owns the cross-government supply response and prioritisation.
Procurement & Logistics Lead
Secures alternative supply and manages constrained distribution.
Clinical Lead
Sets clinical prioritisation and substitution guidance.
Ethics & Allocation Adviser
Owns the fair-allocation framework under scarcity.
Industry Liaison
Engages domestic manufacturers on scale-up and onshoring.
Communications Lead
Manages public messaging on shortage and rationing.
Inject timeline
- Week 0Demand spike
Surge pushes countermeasure usage well above available supply.
- Week 1Export restriction
The main supplier country restricts exports to protect its own stocks.
- Week 1Freight disruption
A key logistics route is disrupted; scheduled deliveries slip.
- Week 2Stockpile threshold
The national stockpile falls to a few weeks of cover.
- Week 2Hoarding signal
Reports of regional and hospital hoarding and grey-market pricing emerge.
- Week 3Substitute shortfall
The clinically inferior substitute is also constrained.
Decision points
D1How do you allocate the scarce countermeasure — by region, by clinical need, or by population share?
- Whether a fair-allocation framework exists and was agreed before the shortage.
- The equity consequences of each rule for the worst-affected regions.
- How allocation is enforced against hoarding and grey-market diversion.
D2Do you release the strategic stockpile now, or hold it for a worse peak?
- Confidence in the demand forecast and the timing of the peak.
- The signal a release sends to the market and the public.
- What happens if the peak is later and higher than modelled.
D3How transparent are you about rationing, given panic-buying risk?
- Transparency and trust vs. the risk of accelerating hoarding.
- Giving clinicians clear prioritisation without alarming the public.
- Consistency of message across regions and providers.
Response playbook
Detect & map
- Identify the exposed input and map dependencies
- Quantify the supply–demand gap
- Activate stockpile governance
- Convene cross-government resilience cell
Allocate
- Publish the allocation framework
- Set clinical prioritisation and substitution
- Control distribution
- Counter hoarding and diversion
Re-supply
- Activate alternative and domestic manufacturing
- Open diplomatic and procurement channels
- Deploy substitutes where clinically acceptable
- Monitor incoming supply
Recover & harden
- Replenish the stockpile
- Diversify suppliers
- Onshore critical inputs
- Update the resilience plan and re-test
After-action questions
- Which single-supplier dependency surprised you — and is it mapped anywhere today?
- Was your allocation framework agreed in advance, or improvised under pressure?
- How long could you actually sustain rationing before the system or public trust broke?
National benchmark references
Real national strategies from the Global Pandemic Preparedness Benchmark that inform this scenario.